-

Shareholder Investigation Launched by Kaskela Law Firm into Fairness of Eventbrite, Inc. (NYSE: EB) Buyout Price; Eventbrite Investors Encouraged to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC has launched an investigation into the fairness of the recently announced proposed buyout of Eventbrite, Inc. (NYSE: EB) shareholders to determine whether the $4.50 per share buyout price undervalues the company’s shares.

Click here to request additional information: https://kaskelalaw.com/case/eventbrite/

On December 4, 2025, Eventbrite announced that it had agreed to be acquired by Bending Spoons at a price of $4.50 per share in cash. Following the closing of the proposed transaction, Eventbrite's shareholders will be cashed out of their investment position and the company's shares will no longer be publicly traded.

The investigation seeks to determine whether Eventbrite investors will be receiving sufficient financial consideration for their shares, and whether the company's officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to the buyout price Bending Spoons. Notably, at the time the proposed transaction was announced, at least one stock analyst was maintaining a price target of $7.00 per share for Eventbrite's shares.

Eventbrite shareholders who believe the buyout price is too low are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 – 0750. Alternatively, investors may contact the firm via email at abell@kaskelalaw.com, or by clicking on the following link (or if necessary, by copying and pasting the link into your browser):

https://kaskelalaw.com/case/eventbrite/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.    
(skaskela@kaskelalaw.com)    
Adrienne Bell, Esq.    
(abell@kaskelalaw.com)    
18 Campus Blvd., Suite 100    
Newtown Square, PA 19073    
(484) 229 - 0750    
www.kaskelalaw.com

Kaskela Law LLC

NYSE:EB

Release Versions

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.    
(skaskela@kaskelalaw.com)    
Adrienne Bell, Esq.    
(abell@kaskelalaw.com)    
18 Campus Blvd., Suite 100    
Newtown Square, PA 19073    
(484) 229 - 0750    
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Reservoir Media, Inc. and Encourages Investors to Contact the Firm – RSVR

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Reservoir Media, Inc. (NASDAQ: RSVR) on behalf of the company's shareholders....

Kaskela Law Firm Reports Ongoing Shareholder Investigation of Priority Technology Holdings, Inc. and Encourages Investors to Contact the Firm – PRTH

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is conducting a stockholder investigation into Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority Technology”). The investigation seeks to determine whether Priority Technology and/or the company’s representatives violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Priority Technology shareholders should contact Kaskela Law (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 2...

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...
Back to Newsroom